热门资讯> 正文

Protalix BioTherapeutics Q1收益预览

2026-05-13 02:07

PROTALIX生物疗法(PLX) 0

Protalix BioTherapeutics (PLX) is scheduled to announce Q1 earnings results on Wednesday, May 13th, before market open.
The consensus EPS estimate is -$0.01, and the consensus revenue estimate is $11.47M (+13.5% Y/Y).
Over the last 1 year, PLX has beaten EPS estimates 50% of the time and has beaten revenue estimates 100% of the time.

More on Protalix BioTherapeutics

Protalix: Elfabrio Struggles Against Oral Competition
Protalix Revenue Miss Overshadowed By Milestone-Backed 2026 Guidance
Protalix BioTherapeutics, Inc. (PLX) Q4 2025 Earnings Call Transcript
Protalix targets $78M–$83M 2026 revenue with EU milestone, advancing PRX-115
Protalix BioTherapeutics misses top-line and bottom-line estimates; gives FY26 outlook

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。